Morgan Stanley Downgrades Haleon (NYSE:HLN) to Equal Weight

Haleon (NYSE:HLN - Get Free Report) was downgraded by equities researchers at Morgan Stanley from an "overweight" rating to an "equal weight" rating in a research report issued on Friday, MarketBeat reports.

Several other analysts also recently commented on HLN. UBS Group upgraded Haleon to a "strong-buy" rating in a research note on Tuesday, October 1st. Sanford C. Bernstein cut Haleon from an "outperform" rating to a "market perform" rating in a research note on Wednesday. Three investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $10.95.

Haleon Stock Down 4.0 %

Shares of Haleon stock traded down $0.38 during trading on Friday, reaching $9.11. 13,143,704 shares of the company traded hands, compared to its average volume of 8,453,087. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. The firm has a market capitalization of $41.24 billion, a PE ratio of 26.79, a P/E/G ratio of 2.95 and a beta of 0.29. The company has a 50 day moving average price of $9.61 and a 200-day moving average price of $9.67. Haleon has a 1-year low of $7.89 and a 1-year high of $10.80.

Institutional Investors Weigh In On Haleon

Hedge funds and other institutional investors have recently made changes to their positions in the business. FMR LLC boosted its stake in Haleon by 5.8% during the 3rd quarter. FMR LLC now owns 104,918,269 shares of the company's stock valued at $1,110,035,000 after purchasing an additional 5,768,117 shares during the last quarter. Sculptor Capital LP lifted its holdings in shares of Haleon by 67.8% in the second quarter. Sculptor Capital LP now owns 8,887,098 shares of the company's stock valued at $73,407,000 after purchasing an additional 3,592,000 shares in the last quarter. Clearbridge Investments LLC boosted its position in shares of Haleon by 8.6% during the second quarter. Clearbridge Investments LLC now owns 41,753,987 shares of the company's stock valued at $344,888,000 after buying an additional 3,307,009 shares during the last quarter. Wellington Management Group LLP grew its holdings in Haleon by 49.9% during the third quarter. Wellington Management Group LLP now owns 9,152,490 shares of the company's stock worth $96,833,000 after buying an additional 3,046,841 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its position in Haleon by 25.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 5,084,202 shares of the company's stock valued at $53,791,000 after buying an additional 1,026,939 shares during the last quarter. 6.67% of the stock is owned by institutional investors.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.